Oxaliplatin + fluorouracil: pharmacokinetics lack synergy

By  

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Toxicodynamics of Oxaliplatin in Rats: Application of a Toxicity Factor to Explain Differences in the Nephrotoxicity and Myelosuppression Induced by Oxaliplatin and the Other Platinum Antitumor Derivatives

By Hanada Kazuhiko   Suda Makoto   Kanai Norihito   Ogata Hiroyasu  

Pharmaceutical Research, Vol. 27, Iss. 9, 2010-09 ,pp. : 1893-1899

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of oxaliplatin during chronomodulated infusion in metastatic gastrointestinal cancer patients: A pilot investigation with preliminary results

By Merkel Ute   Wedding Ulrich   Roskos Martin   Höffken Klaus   Hoffmann Annemarie  

Experimental and Toxicologic Pathology, Vol. 54, Iss. 5-6, 2003-05 ,pp. : 475-479

Urban & Fischer

Access to resources Recommend Favorite

Role of Organic Cation Transporter 1, OCT1 in the Pharmacokinetics and Toxicity of cis-Diammine(pyridine)chloroplatinum(II) and Oxaliplatin in Mice

By Li Shuanglian   Chen Ying   Zhang Shuzhong   More Swati   Huang Xiaozhu   Giacomini Kathleen  

Pharmaceutical Research, Vol. 28, Iss. 3, 2011-03 ,pp. : 610-625

Springer Publishing Company

Access to resources Recommend Favorite

Amphetamine-Type Medicines: A Review of Pharmacokinetics, Pharmacodynamics, and Toxicological Aspects.

By  

Current Clinical Pharmacology, Vol. 8, Iss. 4, 2013-11 ,pp. : 350-357

Bentham Science Publishers

Access to resources Recommend Favorite